InhaltsangabeTable of Contents CANCER GENE THERAPY Introduction Kelly K. Hunt, M.D. and Stephan A. Vorburger, M.D., M.C.R. Vectors 1. Adenovector-mediated Cancer Gene Therapy Bingliang Fang, M.D., Ph.D. and Jack A. Roth, M.D. 2. Efficacy, Toxicity and Immunogenicity of Adenoviral vectors Dmitry Shayakhmetov, Ph.D. 3. Lentiviral and Retroviral Vector Systems Renata Stripecke and Noriyuki Kasahara, M.D., Ph.D. 4. Vaccinia and Pox-Virus Sricharan Chalikonda, M.D. and David L. Bartlett, M.D. 5. Spinning Straw into Gold: The Potential of Replicating Herpes Simplex Virus as a Therapy for Cancer revealed by Genetic Alchemy Ian J. Mohr, Ph.D. 6. Alphavirus Vectors for Gene Therapy Applications Kenneth Lundstrom, Ph.D. 7. Vesicular Stomatitis Virus and RNA Viruses as Gene Therapy Vectors Glen N. Barber, Ph.D. 8. Parvovirus Vectors Selvarangan Ponnazhagan, Ph.D. 9. NonViral Vector Systems Puiyan Lee and Leaf Huang, Ph.D. Gene Therapy Approaches 10. Oncogenes, Tumor Suppressor Genes, and Apoptosis-Inducing Genes Utilized in Cancer Gene Therapy Lidong Zhang and Bingliang Fang, M.D., Ph.D. 11. Gene Silencing Therapy against Cancer ChaoZhong Song, M.D., Ph.D. 12. Tumor Targeting-Retargeted Adenovirus Masato Yamamoto, M.D., Ph.D. and David T. Curiel, M.D., Ph.D. 13. Herpes Simplex Mediated Gene Therapy: Preclinical and and Clinical Approaches Richard H. Pin, Maura Reinblatt, Yuman Fong, and William R. Jarnagin, M.D. 14. Cytokine Gene Therapy for Genitourinary Cancer Terry L. Timme, Tetsuo Fujita, Hongyu Wang, Koji Naruishi, Dov Kadmon, Robert J. Amato, Brian J. Miles, Gustavo Ayala, Thomas M. Wheeler, Bin S. Teh, E. Brian Butler and Timothy C. Thompson, Ph.D. 15. Combination of Gene Therapy with Radiation Anupama Munshi, Ph.D. and Raymond E. Meyn, Ph.D. 16. Gene Transfer into Hematopoietic Stem Cells for Chemoprotection and in vivo Selection Justin C. Roth and Stanton L. Gerson, M.D. 17. NonViral Genetic Vaccines for Cancer Steven R. Little, Daniel G. Anderson Ph.D., and Robert Langer, Sc.D. 18. Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment Anita T. Tandle, Ph.D. and Steven K. Libutti, M.D. 19. TumorSpecific Replicating Adenoviruses: Delta 24 for Human Gliomas Giacomo G. Vecil, M.D., Juan Fueyo, M.D., and Frederick F. Lang, M.D. Clinical Applications 20. Problems, Side Effects and Disappointments in Clinical Cancer Gene Therapy TaChiang Liu and David H. Kirn, M.D. 21. Trials and Tribulations in Developing Clinical Trials of Gene Therapy: E1A for Breast or Ovarian Cancer Naoto Ueno, M.D., Ph.D., Judith K. Wolf, M.D., David M. Gershenson, M.D., Gabriel N. Hortobagyi, M.D., and MienChie Hung, Ph.D. 22. Phase I Clinical Experience with Intravenous Administration of PV701, an Oncolytic Virus Andrew L. Pecora, M.D. and Robert M. Lorence 23. MDA7/IL24 as a MultiModality Therapy for Cancer Sunil Chada, Ph.D., Dora Bocangel, Abujiang Pataer, Abner M. Mhashilkar, Satoshi Inoue, Ryo Miyahara, Jack A. Roth, Elizabeth A. Grimm, Stephen G. Swisher, M.D., Kelly K. Hunt, M.D. and Rajagopal Ramesh, Ph.D. 24. Development of Therapeutic Genes for Breast Cancer Treatment MienChie Hung, Ph.D. and DuenHwa Yan, Ph.D. 25. Steps in a Translational Cancer Gene Therapy Trial Urs W. von Holzen, M.D. and Stephen G. Swisher, M.D.

Hersteller:
Humana Press in Springer Science + Business Media
juergen.hartmann@springer.com
Heidelberger Platz 3
DE 14197 Berlin

Table of Contents CANCER GENE THERAPY Introduction - Kelly K. Hunt, M.D. and Stephan A. Vorburger, M.D., M.C.R. Vectors 1. Adenovector-mediated Cancer Gene Therapy - Bingliang Fang, M.D., Ph.D. and Jack A. Roth, M.D. 2. Efficacy, Toxicity and Immunogenicity of Adenoviral vectors - Dmitry Shayakhmetov, Ph.D. 3. Lentiviral and Retroviral Vector Systems - Renata Stripecke and Noriyuki Kasahara, M.D., Ph.D. 4. Vaccinia and Pox-Virus - Sricharan Chalikonda, M.D. and David L. Bartlett, M.D. 5. Spinning Straw into Gold: The Potential of Replicating Herpes Simplex Virus as a Therapy for Cancer revealed by Genetic Alchemy - Ian J. Mohr, Ph.D. 6. Alphavirus Vectors for Gene Therapy Applications - Kenneth Lundstrom, Ph.D. 7. Vesicular Stomatitis Virus and RNA Viruses as Gene Therapy Vectors - Glen N. Barber, Ph.D. 8. Parvovirus Vectors - Selvarangan Ponnazhagan, Ph.D. 9. Non-Viral Vector Systems - Pui-yan Lee and Leaf Huang, Ph.D. Gene Therapy Approaches 10. Oncogenes, Tumor Suppressor Genes, and Apoptosis-Inducing Genes Utilized in Cancer Gene Therapy - Lidong Zhang and Bingliang Fang, M.D., Ph.D. 11. Gene Silencing Therapy against Cancer - Chao-Zhong Song, M.D., Ph.D. 12. Tumor Targeting-Retargeted Adenovirus - Masato Yamamoto, M.D., Ph.D. and David T. Curiel, M.D., Ph.D. 13. Herpes Simplex Mediated Gene Therapy: Preclinical and and Clinical Approaches - Richard H. Pin, Maura Reinblatt, Yuman Fong, and William R. Jarnagin, M.D. 14. Cytokine Gene Therapy for Genitourinary Cancer - Terry L. Timme, Tetsuo Fujita, Hongyu Wang, Koji Naruishi, Dov Kadmon, Robert J. Amato, Brian J. Miles, Gustavo Ayala, Thomas M. Wheeler, Bin S. Teh, E. Brian Butler and Timothy C. Thompson, Ph.D. 15. Combination of Gene Therapy with Radiation - Anupama Munshi, Ph.D. and Raymond E. Meyn, Ph.D. 16. Gene Transfer into Hematopoietic Stem Cells for Chemoprotection and in vivo Selection - Justin C. Roth and Stanton L. Gerson, M.D. 17. Non-Viral Genetic Vaccines for Cancer - Steven R. Little, Daniel G. Anderson Ph.D., and Robert Langer, Sc.D. 18. Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment - Anita T. Tandle, Ph.D. and Steven K. Libutti, M.D. 19. Tumor-Specific Replicating Adenoviruses: Delta 24 for Human Gliomas - Giacomo G. Vecil, M.D., Juan Fueyo, M.D., and Frederick F. Lang, M.D. Clinical Applications 20. Problems, Side Effects and Disappointments in Clinical Cancer Gene Therapy - Ta-Chiang Liu and David H. Kirn, M.D. 21. Trials and Tribulations in Developing Clinical Trials of Gene Therapy: E1A for Breast or Ovarian Cancer - Naoto Ueno, M.D., Ph.D., Judith K. Wolf, M.D., David M. Gershenson, M.D., Gabriel N. Hortobagyi, M.D., and Mien-Chie Hung, Ph.D. 22. Phase I Clinical Experience with Intravenous Administration of PV701, an Oncolytic Virus - Andrew L. Pecora, M.D. and Robert M. Lorence 23. MDA-7/IL-24 as a Multi-Modality Therapy for Cancer - Sunil Chada, Ph.D., Dora Bocangel, Abujiang Pataer, Abner M. Mhashilkar, Satoshi Inoue, Ryo Miyahara, Jack A. Roth, Elizabeth A. Grimm, Stephen G. Swisher, M.D., Kelly K. Hunt, M.D. and Rajagopal Ramesh, Ph.D. 24. Development of Therapeutic Genes for Breast Cancer Treatment - Mien-Chie Hung, Ph.D. and Duen-Hwa Yan, Ph.D. 25. Steps in a Translational Cancer Gene Therapy Trial - Urs W. von Holzen, M.D. and Stephen G. Swisher, M.D.